NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 84 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $521,721 | -62.4% | 289,845 | -55.8% | 0.03% | -62.2% |
| Q3 2022 | $1,389,000 | -34.2% | 655,338 | -16.5% | 0.09% | -15.1% |
| Q2 2022 | $2,111,000 | -45.6% | 784,798 | -12.2% | 0.11% | -38.4% |
| Q1 2022 | $3,878,000 | -27.3% | 893,561 | -13.2% | 0.17% | -8.5% |
| Q4 2021 | $5,335,000 | -16.8% | 1,029,872 | -1.4% | 0.19% | -6.9% |
| Q3 2021 | $6,412,000 | -46.7% | 1,044,267 | -12.3% | 0.20% | -40.9% |
| Q2 2021 | $12,027,000 | – | 1,190,810 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |